Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Motor imagery abilities in individuals who experience aphantasia.

Neuropsychologia·2026
Same author

Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA.

European journal of heart failure·2026
Same author

ABO-Incompatible Platelet Transfusions and Mortality Risk in Patients With Intracranial Hemorrhage.

Neurosurgery·2026
Same author

ZNFX1 uses two-component ubiquitin circuitry to quarantine viral RNA.

Molecular cell·2026
Same author

Defective cerebrovascular development in mice lacking TFPI is restored by activated protein C.

Blood·2026
Same author

Genome-wide association of pica within a cohort of volunteer blood donors potentially implicates the gene encoding neuropeptide VF.

Transfusion·2026

Related Experiment Video

Updated: May 23, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Population-based screening for anemia using first-time blood donors.

Alan E Mast1, Whitney R Steele, Bryce Johnson

  • 1Blood Center of Wisconsin, Blood Research Institute, Milwaukee, Wisconsin, USA.

American Journal of Hematology
|March 31, 2012
PubMed
Summary

Blood donor hemoglobin levels can serve as a reliable public health resource for anemia surveillance. First-time donor fingerstick hemoglobin values closely approximate U.S. population data, offering a valuable alternative to infrequent surveys.

More Related Videos

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Related Experiment Videos

Last Updated: May 23, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Area of Science:

  • Public Health
  • Hematology
  • Biostatistics

Background:

  • Anemia is a significant public health issue requiring effective surveillance methods.
  • Population-based surveys like NHANES are valuable but infrequent and have limited minority representation.

Purpose of the Study:

  • To evaluate blood donor hemoglobin data as a surrogate for population hemoglobin values from NHANES.
  • To assess the feasibility of using readily available donor databases for anemia surveillance.

Main Methods:

  • Compared blood donor venous and fingerstick hemoglobin values with NHANES data (2005-2008).
  • Utilized demographically stratified analyses and ANOVA.
  • Employed regression analysis to estimate venous hemoglobin from fingerstick measurements.

Main Results:

  • First-time donor venous hemoglobin correlated strongly with NHANES data across demographics.
  • Converted fingerstick hemoglobin values showed good agreement with NHANES data.
  • Donor data revealed smaller racial/ethnic differences in hemoglobin compared to NHANES.

Conclusions:

  • First-time donor fingerstick hemoglobins are a viable proxy for U.S. population hemoglobin levels.
  • Donor hemoglobin data offer a practical resource for continuous anemia surveillance.
  • This approach can supplement traditional surveys for public health monitoring.